Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction (Scientific Reports, (2020), 10, 1, (16596), 10.1038/s41598-020-73593-0)

Ahmed Al‑Darraji; Renée R. Donahue; Himi Tripathi; Hsuan Peng; Bryana M. Levitan; Lakshman Chelvarajan; Dalia Haydar; Erhe Gao; David Henson; John C. Gensel; David J. Feola; Vincent J. Venditto; Ahmed Abdel‑Latif

doi:10.1038/s41598-021-85720-6

Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction (Scientific Reports, (2020), 10, 1, (16596), 10.1038/s41598-020-73593-0)

Ahmed Al‑Darraji
, Renée R. Donahue
, Himi Tripathi
, Hsuan Peng
, Bryana M. Levitan
, Lakshman Chelvarajan
, Dalia Haydar
, Erhe Gao
, David Henson
, John C. Gensel
, David J. Feola
, Vincent J. Venditto
, Ahmed Abdel‑Latif

Producción científica: Comment/debate

Resumen

The Acknowledgements section in this Article is incomplete. “The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center.” should read: “The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center. V.J.V. was supported by the University of Kentucky Center for Biomedical Research Excellence (COBRE) in Pharmaceutical Research and Innovation (CPRI, NIH P20GM130456) and a grant from the National Institutes of Health (R01HL152081).”.

Idioma original	English
Número de artículo	6654
Publicación	Scientific Reports
Volumen	11
N.º	1
DOI	https://doi.org/10.1038/s41598-021-85720-6
Estado	Published - dic 2021

Nota bibliográfica

Publisher Copyright:
© 2021, The Author(s).

Financiación

“The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center.” “The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center. V.J.V. was supported by the University of Kentucky Center for Biomedical Research Excellence (COBRE) in Pharmaceutical Research and Innovation (CPRI, NIH P20GM130456) and a grant from the National Institutes of Health (R01HL152081).” Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Financiadores	Número del financiador
University of Kentucky Markey Comprehensive Cancer Center
University of Kentucky Center for Biomedical Research Excellence
CEPR COBRE
Center Core Support Grant
Office of the Vice President for Research
National Childhood Cancer Registry – National Cancer Institute	P30 CA177558
National Institutes of Health (NIH)	P20GM130456, R01HL152081

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Good health and well being

ASJC Scopus subject areas

General

Acceder al documento

10.1038/s41598-021-85720-6

Otros archivos y enlaces

Huella

Profundice en los temas de investigación de 'Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction (Scientific Reports, (2020), 10, 1, (16596), 10.1038/s41598-020-73593-0)'. En conjunto forman una huella única.

Citar esto

Al‑Darraji, A., Donahue, R. R., Tripathi, H., Peng, H., Levitan, B. M., Chelvarajan, L., Haydar, D., Gao, E., Henson, D., Gensel, J. C., Feola, D. J., Venditto, V. J., & Abdel‑Latif, A. (2021). Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction (Scientific Reports, (2020), 10, 1, (16596), 10.1038/s41598-020-73593-0). Scientific Reports, 11(1), Artículo 6654. https://doi.org/10.1038/s41598-021-85720-6

@article{c9ff29ff298b400aade38ab964bbc071,

title = "Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction (Scientific Reports, (2020), 10, 1, (16596), 10.1038/s41598-020-73593-0)",

abstract = "The Acknowledgements section in this Article is incomplete. {\textquotedblleft}The UK Flow Cytometry \& Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center.{\textquotedblright} should read: {\textquotedblleft}The UK Flow Cytometry \& Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center. V.J.V. was supported by the University of Kentucky Center for Biomedical Research Excellence (COBRE) in Pharmaceutical Research and Innovation (CPRI, NIH P20GM130456) and a grant from the National Institutes of Health (R01HL152081).{\textquotedblright}.",

author = "Ahmed Al‑Darraji and Donahue, \{Ren{\'e}e R.\} and Himi Tripathi and Hsuan Peng and Levitan, \{Bryana M.\} and Lakshman Chelvarajan and Dalia Haydar and Erhe Gao and David Henson and Gensel, \{John C.\} and Feola, \{David J.\} and Venditto, \{Vincent J.\} and Ahmed Abdel‑Latif",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s).",

year = "2021",

month = dec,

doi = "10.1038/s41598-021-85720-6",

language = "English",

volume = "11",

number = "1",

}

Al‑Darraji, A, Donahue, RR, Tripathi, H, Peng, H, Levitan, BM, Chelvarajan, L, Haydar, D, Gao, E, Henson, D, Gensel, JC , Feola, DJ , Venditto, VJ & Abdel‑Latif, A 2021, 'Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction (Scientific Reports, (2020), 10, 1, (16596), 10.1038/s41598-020-73593-0)', Scientific Reports, vol. 11, n.º 1, 6654. https://doi.org/10.1038/s41598-021-85720-6

Author Correction: Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction (Scientific Reports, (2020), 10, 1, (16596), 10.1038/s41598-020-73593-0). / Al‑Darraji, Ahmed; Donahue, Renée R.; Tripathi, Himi et al.
En: Scientific Reports, Vol. 11, N.º 1, 6654, 12.2021.

Producción científica: Comment/debate

TY - JOUR

T1 - Author Correction

T2 - Liposomal delivery of azithromycin enhances its immunotherapeutic efficacy and reduces toxicity in myocardial infarction (Scientific Reports, (2020), 10, 1, (16596), 10.1038/s41598-020-73593-0)

AU - Al‑Darraji, Ahmed

AU - Donahue, Renée R.

AU - Tripathi, Himi

AU - Peng, Hsuan

AU - Levitan, Bryana M.

AU - Chelvarajan, Lakshman

AU - Haydar, Dalia

AU - Gao, Erhe

AU - Henson, David

AU - Gensel, John C.

AU - Feola, David J.

AU - Venditto, Vincent J.

AU - Abdel‑Latif, Ahmed

PY - 2021/12

Y1 - 2021/12

N2 - The Acknowledgements section in this Article is incomplete. “The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center.” should read: “The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center. V.J.V. was supported by the University of Kentucky Center for Biomedical Research Excellence (COBRE) in Pharmaceutical Research and Innovation (CPRI, NIH P20GM130456) and a grant from the National Institutes of Health (R01HL152081).”.

AB - The Acknowledgements section in this Article is incomplete. “The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center.” should read: “The UK Flow Cytometry & Cell Sorting core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center. V.J.V. was supported by the University of Kentucky Center for Biomedical Research Excellence (COBRE) in Pharmaceutical Research and Innovation (CPRI, NIH P20GM130456) and a grant from the National Institutes of Health (R01HL152081).”.

UR - https://www.scopus.com/pages/publications/85102676635

UR - https://www.scopus.com/pages/publications/85102676635#tab=citedBy

U2 - 10.1038/s41598-021-85720-6

DO - 10.1038/s41598-021-85720-6

M3 - Comment/debate

C2 - 33731792

AN - SCOPUS:85102676635

SN - 2045-2322

VL - 11

JO - Scientific Reports

JF - Scientific Reports

IS - 1

M1 - 6654

ER -